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IntrOductIOn
Matricaria chamomilla (syn: M. recutita), commonly known as 
Chamomile or German Chamomile [1] is a valuable plant which 
belongs to the Asteraceae family, which has been used in herbal 
medicine for treatment of wounds, eczema, gout, neurological 
disorders, smallpox and other ailments. Extract of this plant has 
antioxidant, antimicrobial, and mild astringent properties [2]. 
Research done on animals suggests that it has anti-inflammatory 
[3], anti-allergic, anti-hyperglycaemic, antiulcer, antipruritic [4], 
anti-mutagenic and cholesterol-lowering effects [5]. Chamomile 
has been used to cure different gastrointestinal disturbances such 
as stomach upset, flatulence, motion sickness, anorexia, nausea, 
vomiting, diarrhoea and constipation or a combination of both [6]. 
Infections of parasitic worms, malaria, colds and flu symptoms can 
be treated with essential oil of Chamomile. In addition, Chamomile 
extract inhibits the growth of normal cells slightly, but this results 
in a significant reduction in the viability of a variety of cancer cell 
lines [7]. In addition, hydro alcoholic extract of this plant  produces 
an anti-proliferative effect on  yeast cells [8]. Biological activities of 
this plant are related to various classes of bioactive compounds 
which are present in it. Chamomile flowers contain more than 120 
bioactive compounds. The terpenoids, α-bisabolol and its oxides 
and  azulenes are the major constituents of this plant. Various 
therapeutically and biologically active agents have been identified 
to be present in it, including sesquiterpenes, flavonoids, coumarins 
and polyacetylenes [4]. There are many Phenolic compounds 
in extracts of Chamomile flowers, like the flavonoids apigenin, 
patuletin, quercetin, luteolin [9]. Although previous studies have 
demonstrated that Chamomile extract  produces anti-proliferative 
effects on yeast and various human cancer cells, no study has 
yet been conducted to investigate its molecular mechanism in an 
appropriate eukaryotic model. In this regards, medicinal plants have 
 
mostly been used for a long period of time [10,11] and they have 
shown to be a relatively safe and reliable source for preparation 
of new drugs [12,13]. Investigations done on medicinal plants, 
especially on their mechanisms of action, help in improving their 
actions.
Here, the molecular mechanism of action of hydro alcoholic extract 
of Chamomile was studied, to evaluate the potential usefulness of 
this medicinal plant in treatment of human cancers.
MAterIAls And MethOds
This experimental study was conducted in Cellular and Molecular 
Research Center of Shahrekord University of Medical Sciences 
(Iran), over a period of 12 months from September 2013 to 
September 2014.
Plant materials and hydro alcoholic extract preparation: 
Approved M. chamomilla flowers were purchased from Goldarou 
Co. (Isfahan, Iran) and dried under shade at 37°C. The extraction 
was done by percolation method at 15-20°C, using ethanol 50%. 
One hundred grams of powdered chamomile was soaked in 1.2 l 
ethanol and the solution was transferred to a percolator for three 
days, filtered and evaporated at 37°C [14]. The dried material 
was kept at -20°C until it was used. Hydro alcoholic extract was 
dissolved in DMSO (Dimethyl Sulfoxide) (Sigma) to prepare stock 
solutions [7]. It was later added to  culture media to achieve desired 
concentration.
Yeast and culture media: The yeast used in this study was 
Saccharomyces cerevisiae (PTCC 5052) cells which were purcha-
sed from Persian Type Culture Collection in Tehran, Iran. Yeast 
sample was kept at 4°C prior to culture. S. cerevisiae was cultured 
in the  sterile, specific medium of yeast extract, peptone, dextrose 
(YPD) containing 2% glucose, 2% peptone and 1% yeast extract, 
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ABstrAct
Introduction: Over  expression  of  squalene  synthase  gene 
causes induction of growth tumour and reduction of apoptosis. 
This gene which is conserved between Saccharomyces cerevisiae 
yeast and humans, is named (ERG9).
Aim: In this work, we studied the effect of Matricaria recutita 
extract on ERG9 gene (squalene synthase) expression in 
S.cerevisiae which was used as organism model in cancer 
therapy.
Materials and Methods: S. cerevisiae was cultured in YPD 
medium plus 0,250, 1000 and 3000 µg/ml of Matricaria recutita 
extract and we evaluated the (ERG9) gene expression by Real-
time RT-PCR method after 24 hours.
statistical analysis used: At least 3 independent experiments 
were done. Data were analyzed using One-way ANOVA and 
Dunnett’s test. A p-value of less than 0.01 was considered as 
significant.
results:  We  found  that  250,  1000  and  3000  µg/ml  of 
Matricaria recutita extract could reduce expression of ERG9 
gene  significantly  (p<0.01).  Interestingly,  the  expression  of 
this gene was completely inhibited in 1000 and 3000 µg/ml 
concentrations.
conclusion: This  study predicted  that Matricaria recutita ex-
tract  produced anti-cancer effects in humans, because it could 
inhibit the expression of an analogue key gene in this malignant 
disease. Further investigations should be made, to study its 
molecular mechanism of action at the mammal cell level.
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(Corbett), thermo Scientific Maxima SYBR Green/ ROX Q PCR 
Mastermix (2X) kit and specific primers of ERG9 and TUB1, as an 
internal control, genes.
The PCr cycling conditions were as follows: 1 cycle at 95°C 
for 10 min (as an initial denaturation), 40 cycles of 95°C for 20s, 
60°C for 20s and 72°C for 20s and a final extension step 72°C 
5 min. Quantitative analysis of the genes in different groups was 
done by comparative Ct method (2−∆∆Ct, ∆Ct = CtTUB1-CtERG9, ∆∆Ct 
= ∆CtSample-∆CtControl) [16].
stAtIstIcAl AnAlysIs
At least 3 independent experiments were done. Data were 
analyzed  using One-way ANOVA, followed by Dunnett’s test using 
the SPSS software, version 18.0. The results were presented as 
mean ± Standard deviations (SD). A p-value less than 0.01 was 
considered as significant.
results
Optimization of rt-Pcr reaction
Optimizations for every set of primers were done by both 
conventional and quantitative RT-PCR reactions. Conventional 
PCR was performed with a temperature gradient and run on 8% 
polyacrylamide gel [Table/Fig-1a]. Melting curve analysis showed 
unique melting peaks without any primer-dimer formation [Table/
Fig-1b]. PCR efficiency was confiirmed  from the standard curve, 
from  serial dilutions of the pooled cDNAs [Table/Fig-1c].
and was incubated at 30°C for 48 h. After developing pure yeast 
suspension in broth medium, 5×107 cells were transferred to liquid 
medium containing no plant extract [(DMSO 1% as control), 250 
µg/ml, 1000 µg/ml, and 3000µg/ml chamomile hydro alcoholic 
extract] and it was placed in an incubator shaker at 35°C for 24 h 
[8]. To evaluate  the growth rate, we determined the optical density 
at 600nm using a spectrophotometer (DU 800 Beckman Coulter, 
CA, USA).
rna extraction and cDna synthesis: Total RNA was extracted 
according to the kit manufacture’s manual of Biozol Reagent 
(Bioplus). The RNA concentration and purity of each sample  were 
measured by using Thermo Scientific NanoDrop2000 spectro-
photometer.  cDNA was synthesized by a two-step cDNA synthesis 
kit (Vivantis) based on the manufacturer’s protocol using random 
hexamers.
Primer design and real-time polymerase chain reaction: The 
primer sets were designed by online Primer 3 software (http://
www.broad.mit.edu/cgibin/primer/primer3). The following primers 
were used: TUB1: forward 5´CCAAGGGCTATTTACGTGGA3´, 
reverse 5´GGTGTAATGGCCTCTTGCAT3' [15]; ERG9: forward 
5´TGAAAGCATGGGTCTTTTCC3', reverse 5´CAACCCCAGTT-
GTTCGTTTT3'. Each primer sequence was checked in the S. 
cerevisiae transcripttome using the Basic Local Alignment Search 
Tool (BLAST) to ensure detect single gene. The specifiicities of 
primers were verified by gel electrophoresis and melting curve 
analysis and the size of the amplicon was confirmed. Quantification 
of ERG9 gene expression was determined by real-time RT-PCR. 
Quantitative RT-PCR was performed using Rotor-gene 6000 
[table/Fig-1a-c]: Optimization of real time -PCR reaction. (a) Single band of PCR product on polyacrylamide gel,141bp fragment was amplified from TUB1 lines 1-5 and 157bp 
fragment was amplified from ERG9 lines 7-11, Lines 6 and 12: non-template control (NTC). (b) A specific melting curve without primer dimers for amplification on Real-Time PCR. 
(c) Standard curves of a cDNA dilution series for TUB1 and ERG9 showing the amplification efficiency near to 1.00.
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[table/Fig-2]: Effect of Chamomile hydro alcoholic extract on expression of ERG9 
gene in yeast; The medium containing 1% (V/V) DMSO was determined as negative 
control. Values are means ± SD (n = 3). p<0.01 versus control.
contributed greatly to prostate cancer progression. Slusarz A et 
al., study indicated that epigenin decreased Gli1 (a transcription 
factor which causes activation of target genes in this pathway) 
mRNA concentrations [27].
Because Chamomile extract contains more than 120 bioactive 
compounds, it can cause not only reduction in the hedgehog 
signaling pathway by decreasing Gli1 gene expression, but it can 
also cause induced apoptosis and decrease growth of cancer 
cells by decreasing ERG9 gene expression.
Remarkably, as SQS knock down attenuates the invasion potential 
of lung and prostate cancer cells, similar effects can occur when 
cancer cells are treated with the SQS chemical inhibitor i.e. 
Zaragoza acid A. Therefore, SQS inhibitors may have considerable 
potential for antineoplastic intervention [25,26].
This study shows the decrease in ERG9 gene expression with 
Chamomile Extract treatment, but it does not show correlation 
with protein level or SQS activity of Squalene Synthases (SQS).
Hence, further attention should be given to the mechanism 
of action of chamomile extract at the mammal cell level and it 
is recommended that the effective substance of this extract on 
ERG9 gene expression should be identified.
cOnclusIOn
This research demonstrates the molecular mechanism of the anti-
proliferation action of chamomile extract. We found that chamomile 
extract significantly decrease ERG9 mRNA concentration; our 
findings on complete inhibition of ERG9 gene expression in the 
presence of Chamomile extracts concludes that it can be used 
as a prospective available, safer and more affordable anticancer 
agent.
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dIscussIOn
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decrease growth of yeast cells.
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